Skip to content

OIS INDEX: Trump Bump

OIS Index: Trump Bump - Eye On Innovation Article - OIS - Healthegy

The OIS Index closed at 962.42 on Tuesday, a week after Donald Trump’s election. Here’s how the collection of 29 publicly traded ophthalmology companies fared against larger indexes.

OIS Index = 12.7% increase
Russell 3000 = 2.6% increase
NASDAQ Biotech Index = 11.2 % increase
US Medical Device Index = 1% drop

OIS Index | Trump Bump

SHARE THIS ARTICLE WITH YOUR COLLEAGUES:

RECOMMENDED FOR YOU

OIS INDEX Oyster Point

Oyster Point Pharma Goes Public

Digging deep in the retina pipeline

Digging deep in the retina pipeline

Private Financing Trends: Ophthalmology Ranks Tenth

Private Financing Trends: Ophthalmology Ranks Tenth

OIS ISRAEL

OIS’ First International Venue

OIS Index Nov. 2019

OIS Index on Positive Upswing

Opthea’s Star Brightens for Stakeholders

Opthea’s Star Brightens for Stakeholders

About The Author

Michael Lachman

Michael Lachman is President of EyeQ Research, which provides market research, analytics, and strategic advisory to ophthalmic companies and investors. Previously, he was a healthcare investment research analyst with Hambrecht & Quist, ThinkEquity Partners, and SAC Capital, and worked in business development, marketing, and R&D for Johnson & Johnson and Baxter.

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Opthalmologic Innovation To Your Inbox.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.
Scroll To Top